| __timestamp | Alnylam Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 1162636000 |
| Thursday, January 1, 2015 | 41097000 | 1396725000 |
| Friday, January 1, 2016 | 47159000 | 1526100000 |
| Sunday, January 1, 2017 | 76545000 | 1619600000 |
| Monday, January 1, 2018 | 73106000 | 1429100000 |
| Tuesday, January 1, 2019 | 194688000 | 1331200000 |
| Wednesday, January 1, 2020 | 414801000 | 1375200000 |
| Friday, January 1, 2021 | 704143000 | 1563000000 |
| Saturday, January 1, 2022 | 868601000 | 1789600000 |
| Sunday, January 1, 2023 | 1517886000 | 2070000000 |
| Monday, January 1, 2024 | 1924873000 |
Unleashing insights
In the competitive world of biotechnology, Alnylam Pharmaceuticals, Inc. and United Therapeutics Corporation have been vying for dominance in gross profit generation since 2014. Over the past decade, United Therapeutics has consistently outperformed Alnylam, boasting a gross profit that is, on average, nearly four times higher. In 2023, United Therapeutics reached a peak gross profit of approximately $2.07 billion, marking a 78% increase from 2014. Meanwhile, Alnylam has shown impressive growth, with its gross profit surging by over 2,900% from 2014 to 2023, reaching around $1.52 billion. This remarkable growth trajectory highlights Alnylam's aggressive expansion and innovation strategies. As these two companies continue to push the boundaries of medical science, investors and industry watchers alike are keenly observing their financial performances, which reflect broader trends in the biotech sector.
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Key Insights on Gross Profit: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: GSK plc vs United Therapeutics Corporation
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. Trends
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown